Literature DB >> 30691671

Evaluation of 3 T lung magnetic resonance imaging in children with allergic bronchopulmonary aspergillosis: Pilot study.

Kushaljit Singh Sodhi1, Pankaj Gupta2, Amit Shrivastav2, Akshay Kumar Saxena2, Joseph L Mathew3, Meenu Singh3, Ritesh Agarwal4.   

Abstract

OBJECTIVE: To evaluate the diagnostic performance of 3 T lung magnetic resonance imaging (MRI) in children with allergic bronchopulmonary aspergillosis (ABPA).
MATERIALS AND METHODS: This study protocol was approved by the institutional ethics committee. From October 2015 to January 2018, we prospectively evaluated twenty-seven consecutive children with ABPA. The diagnosis of ABPA was made on the ISHAM-ABPA working group criteria. High resolution computed tomography (HRCT) and 3 T MRI of the chest was performed on the same day. Bronchiectasis, consolidation, nodules, and mucus impaction were assessed in all segments. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of MRI were calculated using HRCT findings as the reference standard. Interobserver agreement was calculated using the kappa statistic.
RESULTS: The mean age of the patients was 9.89 years (range: 5-16 years). There were 20 males and 7 females. The sensitivity, specificity, PPV, and NPV for bronchiectasis was 68%, 100%, 100% and 71.43% respectively. The sensitivity, specificity, PPV, and NPV for consolidation was 80%, 100%, 100% and 96% respectively. For detection of nodules, the sensitivity, specificity, PPV, and NPV was 75%, 100%, 100% and 88.46% respectively. There was 100% sensitivity, specificity, PPV and NPV for mucus impaction. There was a high degree of interobserver agreement for MRI findings (k = 0.9-1) as well as agreement (k = 0.7-1) between CT and MRI for all the four findings.
CONCLUSION: With the currently available routine MR sequences, MRI demonstrates high specificity but less sensitivity and negative predictive value to HRCT scan in children with ABPA. Newer MR sequences need to be explored and validated to enhance the potential of lung MRI in ABPA.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABPA; CT; Chest; Imaging; MRI; Pediatrics

Mesh:

Year:  2018        PMID: 30691671     DOI: 10.1016/j.ejrad.2018.12.021

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis.

Authors:  Valentina Fainardi; Chiara Sodini; Michela Deolmi; Andrea Ciuni; Kaltra Skenderaj; Maria Bice Stabile; Cosimo Neglia; Elena Mariotti Zani; Cinzia Spaggiari; Nicola Sverzellati; Susanna Esposito; Giovanna Pisi
Journal:  Microorganisms       Date:  2022-03-29

Review 2.  Molecular Imaging of Pulmonary Inflammation and Infection.

Authors:  Chiara Giraudo; Laura Evangelista; Anna Sara Fraia; Amalia Lupi; Emilio Quaia; Diego Cecchin; Massimiliano Casali
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

Review 3.  Allergic bronchopulmonary aspergillosis.

Authors:  Ritesh Agarwal; Inderpaul S Sehgal; Sahajal Dhooria; Valliappan Muthu; Kuruswamy T Prasad; Amanjit Bal; Ashutosh N Aggarwal; Arunaloke Chakrabarti
Journal:  Indian J Med Res       Date:  2020-06       Impact factor: 2.375

4.  Lung magnetic resonance imaging in pulmonary hydatid in children.

Authors:  Kushaljit Singh Sodhi; Anmol Bhatia; Akshay Kumar Saxena
Journal:  Pol J Radiol       Date:  2022-03-23

Review 5.  Practical protocol for lung magnetic resonance imaging and common clinical indications.

Authors:  Kushaljit Singh Sodhi; Pierluigi Ciet; Shreyas Vasanawala; Juergen Biederer
Journal:  Pediatr Radiol       Date:  2021-05-26

Review 6.  Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis.

Authors:  Birce Sunman; Dilber Ademhan Tural; Beste Ozsezen; Nagehan Emiralioglu; Ebru Yalcin; Uğur Özçelik
Journal:  Front Pediatr       Date:  2020-10-20       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.